Intramolecular signal transduction by the bradykinin B2 receptor

被引:2
|
作者
Mueller, S [1 ]
Liebmann, C [1 ]
Reissmann, S [1 ]
机构
[1] Univ Jena, Inst Biochem & Biophys, D-07743 Jena, Germany
关键词
human bradykinin receptor B-2; mutants; functional characterization; MAP kinase; inositolphosphates; arachidonic acid; radioligand binding;
D O I
10.1016/S1567-5769(02)00167-4
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
To study the intramolecular signal transduction, we performed single point and cassette mutations in transmembranal and intracellular regions of the bradykinin B-2 receptor. We studied the influence of the two intramembranal Cys residues at positions 304 and 348, the role of Arg at position 177 in the highly conserved tripeptide sequence Asp-Arg-Tyr, the cytosolic G-protein binding area, and attempted to verify the general hypothesis of an ion tunnel-like interface in GPCRs. Wild type receptor, Histagged receptor, and His-tagged mutant receptors were expressed in COS-7 cells and functionally compared by bradykinin-induced formation of inositolphosphate and arachidonic acid. To investigate the expression, all mutants were modified at the N-terminus by insertion of two successive His-tags and detected with an anti-poly-His antibody. Replacement of the second and third cytosolic loop by a loop from another membrane protein as well as single replacement of Arg at position 177 by Ala leads to a fully inactive receptor mutant without any ligand binding affinity and stimulatory activity. Mutants with replacement of Cys residues 304 and 348 by Ser showed only moderate effects. Regardless of the replacement of Asp 407 by Ala, the receptor is able to increase the agonist-induced levels of inositolphosphate and of arachidonic acid, indicating that our studies can not verify the postulated ion tunnel hypothesis. (C) 2002 Published by Elsevier Science B.V.
引用
收藏
页码:1763 / 1770
页数:8
相关论文
共 50 条
  • [11] Cardioprotective properties of bradykinin: role of the B2 receptor
    Athanasios J Manolis
    Maria E Marketou
    Irene Gavras
    Haralambos Gavras
    Hypertension Research, 2010, 33 : 772 - 777
  • [12] Negative cooperativity in the human bradykinin B2 receptor
    Pizard, A
    Marchetti, J
    Allegrini, J
    Alhenc-Gelas, F
    Rajerison, RM
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (03) : 1309 - 1315
  • [13] Bradykinin B2 receptor expression in the porcine ovary
    Kimura, A
    Ohkura, R
    Kihara, T
    Takahashi, T
    PERSPECTIVE IN COMPARATIVE ENDOCRINOLOGY: UNITY AND DIVERSITY, 2001, : 1131 - 1134
  • [14] New perspectives for bradykinin B2 receptor in nephroprotection
    Buleon, Marie
    Mehrenberger, Marion
    Pecher, Christiane
    Praddaude, Francoise
    Couture, Rejean
    Tack, Ivan
    Girolami, Jean-Pierre
    M S-MEDECINE SCIENCES, 2007, 23 (12): : 1141 - 1147
  • [15] Bradykinin B2 receptor as a potential therapeutic target
    Heitsch, H
    DRUG NEWS & PERSPECTIVES, 2000, 13 (04) : 213 - 225
  • [16] Cardioprotective properties of bradykinin: role of the B2 receptor
    Manolis, Athanasios J.
    Marketou, Maria E.
    Gavras, Irene
    Gavras, Haralambos
    HYPERTENSION RESEARCH, 2010, 33 (08) : 772 - 777
  • [17] Bradykinin B2 receptor blockade and intradialytic hypotension
    Jorge L. Gamboa
    Cindy A. Mambungu
    Adrienne R. Clagett
    Hui Nian
    Chang Yu
    T. Alp Ikizler
    Nancy J. Brown
    BMC Nephrology, 24
  • [18] Search for autoantibodies to the human bradykinin B2 receptor
    Micke, P
    Blaukat, A
    MullerEsterl, W
    IMMUNOPHARMACOLOGY, 1997, 36 (2-3): : 109 - 113
  • [19] Bradykinin B2 receptor antagonists for the treatment of pain
    Dziadulewicz, EK
    ANNUAL REPORTS IN MEDICINAL CHEMISTRY, VOL 39, 2004, 39 : 113 - 124
  • [20] Benzodiazepines as selective bradykinin B2 receptor antagonists
    Leung, C
    Santhakumar, V
    Tomaszewski, M
    Walpole, C
    Woo, S
    Adam, L
    Butterworth, J
    Godbout, C
    Payza, K
    Roumi, M
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2005, 230 : U2564 - U2565